Abstract:OBJECTIVE:To infect dendritic cells (DC) by recombinant human adeno-associated virus (rh-AAV) vector with CEA gene to generate antigen-specific CTL cells in vitro and to assay the CEA specific cytotoxic T lymphocyte(CTL), response to CD44(+)CD24(-/low) breast cancer stem cells.METHODS:Peripheral blood mononuclear cells were induced to generate DCs by cytokines interleukin-4(IL-4), granulocyte-macrophage colony-stimulating factor(GM-CSF)and tumor necrosis factor-alpha(TNF-α) while T lymphocytes were cultured with cytokines interleukin-2(IL-2). DCs were infected by CEA gene containing rh-AAV. After being matured, DCs were co-cultured with T cells to generate CTL cells. CD44(+)CD24(-/low) breast cancer stem cells were sorted out from MCF-7 and MDA-MB-231 cells. CEA specific CTL response to CD44(+)CD24(-/low) breast cancer stem cells was assayed by MTT method.RESULTS:The percentages of CD44(+)CD24(-/low) breast cancer stem cells subsets in MCF-7 and MDA-MB-231 were 5.1% and 76.3% respectively. DCs transfected with CEA gene could induce CEA antigen CTLs response. The killing ratio of MCF-7 cells in CEA gene transfection group was 46.5% plusmn; 15.0% with significant difference (P=0.009) as compared with that of CEA gene untransfection group. As for CD44(+)CD24(-/low) breast cancer stem cells subset from MCF-7 cells, CEA gene transfection group resulted in a higher killing ratio of 44.7% ± 28.2% as compared with that of CEA untransfection group. While the inhibitory rate of non-breast cancer stem cells subset from MCF-7 cells in CEA gene transfection group was 50.6% ± 22.2% (P=0.05). CTL cells generated by DCs transfected with CEA gene did not show inhibitory activity to MDA-MB-231 breast cancer cells (without CEA expression) as compared with CEA gene untransfection group. It was the same in CD44(+)CD24(-/low) breast cancer stem cells subset and non-breast cancer stem cells subset from MDA-MB-231 breast cancer cells (P>0.05).CONCLUSION:DCs infected by rh-AAV with CEA gene could induce antigen-specific CTL response to kill CEA expressing breast cancer cells involved in CD44(+)CD24(-/low) breast cancer stem cells subset. It suggests that immune therapy might be a potential treatment of breast cancer stem cells.

A Study of the Inhibitory Effect of a Recombinant CEA Vaccinia Virus Inocnlation on Mouse CE~A Positive Tumor

The construction of recombinant CEA gene vaccine and its immune effect

Study on antitumor effect of minigene DNA vaccine derived from Carcinoembry-onic Antigen ( CEA) gene in mice

Preliminary study on antitumor effect of C215gene transfected tumor vaccine and monoclonal antibody-superantigen fusion protein C 215Fab-SEA

Tumor specific immune response induced by three tandem repeats of CEA mini gene DNA vaccine and safety evaluation

CEA Nucleic Acid Vaccine Induces Special Cellular Immune Response to a Carcinoembryonic Antigen in Mice

The Inhibitory Effects of the DNA Vaccine Co-Expressing CEA Tandem Repeat Epitopes and FL on the in Vivo Growth of Heptocarcinomas in Mice

Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8 + CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells

The Ectopic Expression of Survivin T34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer

DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice.

A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity

Observation of anti tumor activity in vivo of three tandem repeats of minigene DNA vaccine derived from CEA gene

Anticancer Effect of Mouse Marrow-Derived Dendritic Cells Transfected by Pcdna3-Hcea

[Dendritic Cells Infected by Recombinant Adeno-Associated Virus with CEA Gene to Induce Antigen-Specific CTL Response to CD44(+)CD24(-/low) Cells from MCF-7 Breast Cancer Cell Line].

Study on the Effect of Human CMV Early Transcriptional Enhancer on Human CEA Promoter

Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect.

Antitumor effects of the fusion protein of transmembrane-staphylococcal enterotoxin A

Specific proliferation of lymphocytes from mice induced by carcinoembryonic antigen minigene peptide

[Antitumor Effect of EGFRvIII/HBcAg Recomibinant Vaccine on Murine Transplanted Tumor].

Induction of specific anti-CEA responses by DNA vaccination with fusion sequence of CEA repeat epitopes and heterogenous HSP70 in mice

Preparation of Carcinoembryonic Antigen Positive Tumor Gene Vaccine Capsules for Oral Use